Finance Foggle

Centene Q2 Loss Highlights Rising Costs Key Takeaways Centene posted a $253M Q2 loss , flipping from a $1.1B profit in 2024 . Medical cost ratio (MCR) surged to 93% , far exceeding Wall Street’s 89.3% forecast . Stock plunged 14.5%  premarket, hitting a decade low and dragging down peers Elevance Health and Molina Healthcare . Loss drivers : Medicaid behavioral/home health costs, ACA risk-adjustment revenue cuts, and high-cost drugs . Corrective action : Premium hikes for 2026 ACA plans in "substantial majority" of states . The Earnings Shock Centene bled red. $253 million vanished in Q2. Last year? A crisp $1.1 billion profit . Premium revenue climbed to $42.5 billion, up 18%, but medical costs devoured it . The street expected an $0.86 per share profit. Instead, Centene coughed up a $0.16 loss . Analysts stared at their screens. Julie Utterback at Morningstar called the 93% medical cost ratio "surprisingly high" . All business lines burned. The ACA marketplace? Th...

  Yield Curve Forecasting and Economic Analysis Key Takeaways Yield curves normalized in early 2025 after prolonged inversion, with the 2s/10s spread turning positive at ~40 basis points . Term premiums surged to decade highs due to tariff uncertainty and deficit concerns, driving long-end volatility . Recession probability rose to 46% as growth forecasts were slashed (2025 GDP: 0.3% vs. prior 1.2%) . Vasicek and DSGE models outperformed surveys by incorporating real-time market data and tariff shocks . Tactical trades : Curve flatteners (short 2Y/long 10Y) gained as long-end yields defied hawkish Fed rhetoric . 1. Yield Curve Normalization: The Great Un-Inversion 2025 started with a key shift: the deeply inverted Treasury curve finally turned positive. After 2+ years of negative spreads, the 2-year/10-year gap hit +40 basis points by January. This wasn’t about economic euphoria though. Federal Reserve cuts and "bumpy inflation" narratives drove the move, flattening the short...